268 related articles for article (PubMed ID: 20473312)
1. Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia.
Kleppe M; Lahortiga I; El Chaar T; De Keersmaecker K; Mentens N; Graux C; Van Roosbroeck K; Ferrando AA; Langerak AW; Meijerink JP; Sigaux F; Haferlach T; Wlodarska I; Vandenberghe P; Soulier J; Cools J
Nat Genet; 2010 Jun; 42(6):530-5. PubMed ID: 20473312
[TBL] [Abstract][Full Text] [Related]
2. PTPN2 negatively regulates oncogenic JAK1 in T-cell acute lymphoblastic leukemia.
Kleppe M; Soulier J; Asnafi V; Mentens N; Hornakova T; Knoops L; Constantinescu S; Sigaux F; Meijerink JP; Vandenberghe P; Tartaglia M; Foa R; Macintyre E; Haferlach T; Cools J
Blood; 2011 Jun; 117(26):7090-8. PubMed ID: 21551237
[TBL] [Abstract][Full Text] [Related]
3. Clinical and biological features of PTPN2-deleted adult and pediatric T-cell acute lymphoblastic leukemia.
Alcantara M; Simonin M; Lhermitte L; Touzart A; Dourthe ME; Latiri M; Grardel N; Cayuela JM; Chalandon Y; Graux C; Dombret H; Ifrah N; Petit A; Macintyre E; Baruchel A; Boissel N; Asnafi V
Blood Adv; 2019 Jul; 3(13):1981-1988. PubMed ID: 31270080
[TBL] [Abstract][Full Text] [Related]
4. Mutation analysis of the tyrosine phosphatase PTPN2 in Hodgkin's lymphoma and T-cell non-Hodgkin's lymphoma.
Kleppe M; Tousseyn T; Geissinger E; Kalender Atak Z; Aerts S; Rosenwald A; Wlodarska I; Cools J
Haematologica; 2011 Nov; 96(11):1723-7. PubMed ID: 21791476
[TBL] [Abstract][Full Text] [Related]
5. Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32).
De Keersmaecker K; Graux C; Odero MD; Mentens N; Somers R; Maertens J; Wlodarska I; Vandenberghe P; Hagemeijer A; Marynen P; Cools J
Blood; 2005 Jun; 105(12):4849-52. PubMed ID: 15713800
[TBL] [Abstract][Full Text] [Related]
6. Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia.
Vanden Bempt M; Demeyer S; Broux M; De Bie J; Bornschein S; Mentens N; Vandepoel R; Geerdens E; Radaelli E; Bornhauser BC; Kulozik AE; Meijerink JP; Bourquin JP; de Bock CE; Cools J
Cancer Cell; 2018 Aug; 34(2):271-285.e7. PubMed ID: 30107177
[TBL] [Abstract][Full Text] [Related]
7. NUP214-ABL1-mediated cell proliferation in T-cell acute lymphoblastic leukemia is dependent on the LCK kinase and various interacting proteins.
De Keersmaecker K; Porcu M; Cox L; Girardi T; Vandepoel R; de Beeck JO; Gielen O; Mentens N; Bennett KL; Hantschel O
Haematologica; 2014 Jan; 99(1):85-93. PubMed ID: 23872305
[TBL] [Abstract][Full Text] [Related]
8. The role of TC-PTP (PTPN2) in modulating sensitivity to imatinib and interferon-α in CML cell line, KT-1 cells.
Nishiyama-Fujita Y; Shimizu T; Sagawa M; Uchida H; Kizaki M
Leuk Res; 2013 Sep; 37(9):1150-5. PubMed ID: 23759247
[TBL] [Abstract][Full Text] [Related]
9. TLX1-induced T-cell acute lymphoblastic leukemia.
De Keersmaecker K; Ferrando AA
Clin Cancer Res; 2011 Oct; 17(20):6381-6. PubMed ID: 21705452
[TBL] [Abstract][Full Text] [Related]
10. A cell type-specific role of protein tyrosine phosphatase non-receptor type 2 in regulating ER stress signalling.
Kasper SH; Spalinger MR; Raselli T; Scharl M
Digestion; 2015; 91(3):248-56. PubMed ID: 25823847
[TBL] [Abstract][Full Text] [Related]
11. Benzoquinone, a leukemogenic metabolite of benzene, catalytically inhibits the protein tyrosine phosphatase PTPN2 and alters STAT1 signaling.
Duval R; Bui LC; Mathieu C; Nian Q; Berthelet J; Xu X; Haddad I; Vinh J; Dupret JM; Busi F; Guidez F; Chomienne C; Rodrigues-Lima F
J Biol Chem; 2019 Aug; 294(33):12483-12494. PubMed ID: 31248982
[TBL] [Abstract][Full Text] [Related]
12. TC-PTP and PTP1B: Regulating JAK-STAT signaling, controlling lymphoid malignancies.
Pike KA; Tremblay ML
Cytokine; 2016 Jun; 82():52-7. PubMed ID: 26817397
[TBL] [Abstract][Full Text] [Related]
13. NUP214-ABL1 in adult T-ALL: the GMALL study group experience.
Burmeister T; Gökbuget N; Reinhardt R; Rieder H; Hoelzer D; Schwartz S
Blood; 2006 Nov; 108(10):3556-9. PubMed ID: 16873673
[TBL] [Abstract][Full Text] [Related]
14. Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia.
Graux C; Cools J; Melotte C; Quentmeier H; Ferrando A; Levine R; Vermeesch JR; Stul M; Dutta B; Boeckx N; Bosly A; Heimann P; Uyttebroeck A; Mentens N; Somers R; MacLeod RA; Drexler HG; Look AT; Gilliland DG; Michaux L; Vandenberghe P; Wlodarska I; Marynen P; Hagemeijer A
Nat Genet; 2004 Oct; 36(10):1084-9. PubMed ID: 15361874
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in
Sharp RC; Beg SA; Naser SA
Front Cell Infect Microbiol; 2018; 8():11. PubMed ID: 29423382
[TBL] [Abstract][Full Text] [Related]
16. Prognostic utility of key copy number alterations in T cell acute lymphoblastic leukemia.
Kumari S; Ali MS; Singh J; Arora M; Verma D; Pandey AK; Benjamin M; Bakhshi S; Palanichamy JK; Sharma A; Singh I; Tanwar P; Singh AR; Pushpam D; Qamar I; Chopra A
Hematol Oncol; 2022 Oct; 40(4):577-587. PubMed ID: 35644022
[TBL] [Abstract][Full Text] [Related]
17. Loss of protein tyrosine phosphatase, non-receptor type 2 is associated with activation of AKT and tamoxifen resistance in breast cancer.
Karlsson E; Veenstra C; Emin S; Dutta C; Pérez-Tenorio G; Nordenskjöld B; Fornander T; Stål O
Breast Cancer Res Treat; 2015 Aug; 153(1):31-40. PubMed ID: 26208487
[TBL] [Abstract][Full Text] [Related]
18. NUP214-ABL1 positive T-cell acute lymphoblastic leukemia patient shows an initial favorable response to imatinib therapy post relapse.
Clarke S; O'Reilly J; Romeo G; Cooney J
Leuk Res; 2011 Jul; 35(7):e131-3. PubMed ID: 21489623
[No Abstract] [Full Text] [Related]
19. The ARF tumor suppressor in acute leukemias: insights from mouse models of Bcr-Abl-induced acute lymphoblastic leukemia.
Williams RT; Sherr CJ
Adv Exp Med Biol; 2007; 604():107-14. PubMed ID: 17695724
[TBL] [Abstract][Full Text] [Related]
20. The TLX1 oncogene drives aneuploidy in T cell transformation.
De Keersmaecker K; Real PJ; Gatta GD; Palomero T; Sulis ML; Tosello V; Van Vlierberghe P; Barnes K; Castillo M; Sole X; Hadler M; Lenz J; Aplan PD; Kelliher M; Kee BL; Pandolfi PP; Kappes D; Gounari F; Petrie H; Van der Meulen J; Speleman F; Paietta E; Racevskis J; Wiernik PH; Rowe JM; Soulier J; Avran D; Cavé H; Dastugue N; Raimondi S; Meijerink JP; Cordon-Cardo C; Califano A; Ferrando AA
Nat Med; 2010 Nov; 16(11):1321-7. PubMed ID: 20972433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
